Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: A display device comprises a substrate; a circuit array layer comprising pixel drivers, data lines, first dummy lines, and second dummy lines; and a light emitting array layer. The display area comprises middle, first side, and second side regions. The data lines comprise first, second, and third data lines disposed in the middle, first side, and second side regions, respectively. The first dummy lines comprise a first data detour line disposed in the first side region and adjacent to a part of the second data line, and auxiliary lines. The second dummy lines comprise a second data detour line configured to connect the first data detour line to the third data line, and additional lines. The auxiliary lines comprise a bias auxiliary line to which a bias power is applied; and a second power auxiliary line to which a second power is applied.

Abstract: An example content playing apparatus includes an output unit configured to output an image and voice; a user recognition unit configured to recognize a plurality of users viewing content played by the output unit; and a controller configured to select at least one of the plurality of users based on predetermined criteria and control playing of the content according to the at least one selected user.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: An example content playing apparatus includes an output unit configured to output an image and voice; a user recognition unit configured to recognize a plurality of users viewing content played by the output unit; and a controller configured to select at least one of the plurality of users based on predetermined criteria and control playing of the content according to the at least one selected user.

Abstract: An example content playing apparatus includes an output device including a display and a speaker; and one or more controllers configured to recognize a plurality of users viewing content played by the output device, select at least one of the plurality of users based on one or more criteria, and control playing of the content according to the at least one selected user.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: Provided is an image processing method including: displaying an image including a plurality of objects; receiving a selection of an object from among the plurality of objects; receiving a depth adjustment input; changing a depth of the selected object based on the depth adjustment input; generating a depth adjusted image file of the image based on the changed depth; and displaying a depth adjusted image based on the generated depth adjusted image file.

Abstract: Provided is an image processing method including: displaying an image including a plurality of objects; receiving a selection of an object from among the plurality of objects; receiving a depth adjustment input; changing a depth of the selected object based on the depth adjustment input; generating a depth adjusted image file of the image based on the changed depth; and displaying a depth adjusted image based on the generated depth adjusted image file.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: Provided is a user device including: a storage configured to store data; and a controller configured to recognize a person included in an image captured by the user device or received by the user device from an external source, and change a part of the image corresponding to the recognized person to be unrecognizable in response to a degree of closeness between the recognized person and a user of the user device being lower than a predetermined level based on the data stored in the storage.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.

Abstract: Provided is an image processing method including: displaying an image including a plurality of objects; receiving a selection of an object from among the plurality of objects; receiving a depth adjustment input; changing a depth of the selected object based on the depth adjustment input; generating a depth adjusted image file of the image based on the changed depth; and displaying a depth adjusted image based on the generated depth adjusted image file.

Abstract: An example content playing apparatus includes: an output device including a display and a speaker; and one or more controllers configured to recognize a plurality of users viewing content played by the output device, select at least one of the plurality of users based on one or more criteria, and control playing of the content according to the at least one selected user.

Abstract: Provided is a user device including: a storage configured to store data; and a controller configured to recognize a person included in an image captured by the user device or received by the user device from an external source, and change a part of the image corresponding to the recognized person to be unrecognizable in response to a degree of closeness between the recognized person and a user of the user device being lower than a predetermined level based on the data stored in the storage.

Abstract: The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.